Daniel Donovan Net Worth

What's Daniel Donovan's mailing address?

Daniel's mailing address filed with the SEC is 712 VISTA BLVD #305, , WACONIA, MN, 55387.

Insiders trading at Panbela Therapeutics

Over the last 4 years, insiders at Panbela Therapeutics have traded over 51,741$ worth of Panbela Therapeutics stock and bought 406,888 units worth 0$ . The most active insiders traders include Sachs Group Incgoldman Sach...、Donald Robert Schemel、Michael T. Cullen. On average, Panbela Therapeutics executives and independent directors trade stock every 67 days with the average trade being worth of 27,986$. The most recent stock trade was executed by Sachs Group Incgoldman Sach... on 8 November 2023, trading 72,874 units of PBLA stock currently worth 51,741$.

What does Panbela Therapeutics do?

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.

Panbela Therapeutics executives and stock owners

Panbela Therapeutics executives and other stock owners filed with the SEC include:

• Dr. Jennifer K. Simpson C.R.N.P., CRNP, M.S.N., Ph.D.,
  CEO, Pres & Director
• Susan Horvath,
  VP of Fin., CFO, Sec. & Treasurer
• Dr. Elizabeth Bruckheimer Ph.D.,
  VP & Chief Scientific Officer
• Dr. Suzanne Gagnon,
  Chief Medical Officer & Director
• Tammy Groene,
  VP of Operations
• Dr. Thomas X. Neenan Ph.D.,
  Co-Founder & Chief Scientific Officer
• Suzanne Gagnon,
  Director
• Paul W. Schaffer,
  Director
• Jeffrey S Mathiesen,
  Director
• Susan Horvath,
  V.P. of Finance & CFO
• Michael T. Cullen,
  Director
• Jennifer K. Simpson,
  President and CEO
• Donald Robert Schemel,
  Director
• Arthur Fratamico,
  Director
• Sachs Group Incgoldman Sach...,
  
• Jeffrey E. Jacob,
  Director
• Daniel Donovan,
  Director